Approaches to differentiating pluripotent stem cells (Pscs) into neurons currently face two major challenges-(i) generated cells are immature, with limited functional properties; and (ii) cultures exhibit heterogeneous neuronal subtypes and maturation stages. using lineage-determining transcription factors, we previously developed a single-step method to generate glutamatergic neurons from human Pscs. here, we show that transient expression of the transcription factors Ascl1 and dlx2 (Ad) induces the generation of exclusively GABAergic neurons from human Pscs with a high degree of synaptic maturation. these Ad-induced neuronal (in) cells represent largely nonoverlapping populations of GABAergic neurons that express various subtype-specific markers. We further used Ad-in cells to establish that human collybistin, the loss of gene function of which causes severe encephalopathy, is required for inhibitory synaptic function. the generation of defined populations of functionally mature human GABAergic neurons represents an important step toward enabling the study of diseases affecting inhibitory synaptic transmission.
Approaches to differentiating pluripotent stem cells (Pscs) into neurons currently face two major challenges-(i) generated cells are immature, with limited functional properties; and (ii) cultures exhibit heterogeneous neuronal subtypes and maturation stages. using lineage-determining transcription factors, we previously developed a single-step method to generate glutamatergic neurons from human Pscs. here, we show that transient expression of the transcription factors Ascl1 and dlx2 (Ad) induces the generation of exclusively GABAergic neurons from human Pscs with a high degree of synaptic maturation. these Ad-induced neuronal (in) cells represent largely nonoverlapping populations of GABAergic neurons that express various subtype-specific markers. We further used Ad-in cells to establish that human collybistin, the loss of gene function of which causes severe encephalopathy, is required for inhibitory synaptic function. the generation of defined populations of functionally mature human GABAergic neurons represents an important step toward enabling the study of diseases affecting inhibitory synaptic transmission.
Excitation and inhibition are the two basic interactions between neurons, which utilize glutamate and γ-aminobutyric acid (GABA) as the major neurotransmitters for excitatory and inhibitory signals, respectively. Abnormal GABAergic neuron function has been associated with multiple neurodevelopmental and neurodegenerative disorders. Considerable efforts have thus focused on deriving GABAergic neurons from human induced pluripotent stem (iPS) cells and embryonic stem (ES) cells as a system to study pathogenesis and identify potential therapeutic targets [1] [2] [3] [4] . These studies endeavored to recapitulate developmental processes and derive properly regionalized neural progenitor cells. While this approach likely generates neuronal subtypes that are derived from regionally specified progenitors during development, it presents three important obstacles for translational research. First, spontaneous differentiation of neural progenitor cells leads to mixed neuronal cultures. Second, functional maturation requires extended culture periods, which complicates experimental design. Finally, multistage and prolonged differentiation procedures present technical challenges for reproducibility and consistency.
Generation of pure GABAergic neurons by transcription factor programming
To overcome these problems, we and others have developed methods to directly convert fibroblasts into iN cells using defined reprogramming factors [5] [6] [7] [8] [9] [10] [11] [12] . More recently, we extended this directreprogramming approach to iPS and ES cells 5, 13, 14 and demonstrated that the transcription factor Ngn2, or Neurod1, could rapidly convert human iPS and ES cells into glutamatergic iN cells 13 . In the current study, we show that Ascl1 and Dlx2 together induce the differentiation of human neurons with homogeneous GABAergic neurotransmitter specification. These iN cells expressed genes representing GABAergic neuron subtypes of the telencephalon and diencephalon but not of the hindbrain or spinal cord, and the cells expressed subtype-specific markers somatostatin (SST), calbindin (CB) and calretinin (CR) in largely nonoverlapping subpopulations. We also illustrate that GABAergic iN cells can be used for analyzing inhibitory synapse-specific phenotypes associated with a human neurological disorder. In combination with our previously established glutamatergic Ngn2-iN cells, our approach provides a new platform for cellular modeling of human diseases.
results identification of factors to induce GABAergic neurons
We previously observed that Ngn2, or Neurod1, rapidly converted ES and iPS cells into glutamatergic iN cells 13 . Notably, we also found that forced expression of Ascl1-a basic helix-loop-helix (bHLH) factor not conventionally associated with cell fate determination of glutamatergic neurons-induces excitatory iN cells from human PSCs with slower conversion kinetics 14 . In an effort to improve Ascl1-mediated neuronal induction, we found that coexpression of the zinc finger protein Myt1-like (Myt1l) greatly accelerated the appearance of morphologically complex iN cells (Supplementary Fig. 1) .
In order to promote the GABAergic cell fate, we cloned six transcription factors known to play important roles during the formation of inhibitory neurons and expressed each of the factors together with Ngn2, Neurod1 or Ascl1 + Myt1l (collectively termed AM) in human ES cells using doxycycline-inducible lentiviral vectors. We cultured the transduced cells with mouse glia and performed patch-clamp recordings 28 d later to assess the formation of functional inhibitory synapses ( Supplementary  Fig. 1 ). The iN cells generated by various transcription factor combinations displayed three different patterns of spontaneous synaptic currents-exclusively excitatory postsynaptic currents (EPSCs), exclusively inhibitory postsynaptic currents (IPSCs), or both EPSCs and IPSCs (mixed currents). Of note, the combination of AM factors together with Dlx2 (AMD pool) produced cells with only IPSCs, which suggested that the cultures consisted of largely homogenous GABAergic neurons ( Fig. 1a and Supplementary  Fig. 1 ). We therefore decided to further characterize the iN cells generated by AMD.
At 4 weeks post-exogenous gene induction (WPI), 93.2 ± 3.4% of all human cells were MAP2 positive, indicating successful neuronal conversion of almost the entire ES cell population (Fig. 1b) . More importantly, the vast majority of iN cells expressed markers for GABAergic neurons, including the pan-DLX proteins (91.9% ± 6.6%), GABA (81.4% ± 4.7%), GAD1/2 (GAD67/65) (83.5% ± 6.7%) and vesicular GABA transporter vGAT (SLC32A1) (Fig. 1c-g ). Whole-cell patch-clamp recordings showed that the cells were able to fire repetitive action potentials with prominent spike adaptation upon depolarization, and they exhibited both active and passive membrane properties indicating functional maturation (Fig. 1h,i) . The AMD-induced neurons displayed spontaneous IPSCs and generated large GABA A -receptor-mediated evoked IPSCs upon extracellular field stimulations, confirming the predominant formation of inhibitory synapses (Fig. 1j,k) . Moreover, when cocultured with Ngn2-iN cells, the AMD-induced neurons displayed both EPSCs and IPSCs, which indicated that AM + one factor Neurod1 + one factor Ngn2 + one factor a n (%) 0.01 despite having a presynaptic specification for GABAergic outputs, the AMD-iN cells are fully competent to receive excitatory synaptic inputs from glutamatergic Ngn2-iN cells (Fig. 1l,m) .
To assess the reproducibility of our protocol among multiple PSC lines, we transduced another three independent iPS cell lines and quantified intrinsic membrane properties, including the frequency and amplitude of spontaneous IPSCs, of the AMD-induced neurons. All these parameters were statistically indistinguishable (one-way ANOVA, P > 0.05) among iN cells derived from different cell lines (Supplementary Fig. 2 ). We conclude that the combined expression of Ascl1, Myt1l and Dlx2 induces the differentiation of human PSCs into a virtually homogenous population of GABAergic neurons with high yield and reproducibility.
Amd-in cells exhibit forebrain GABAergic gene signatures
To characterize the AMD-iN cells, we performed RNA-seq on human AMD-iN cells cocultured with mouse glia for 4 weeks and computationally eliminated the mouse reads. AMD-iN cells robustly expressed markers of telencephalon such as FOXG1; whereas markers of the midbrain, hindbrain and spinal cord were largely absent (Supplementary Fig. 3 ). Numerous genes known to be expressed in GABAergic neurons 15 and involved in GABAergic interneuron identity, maturation and functionsuch as DLX1/5/6, GAD1/2 and vGAT-were highly expressed in AMD-iN cells; transcripts of excitatory neuron genes vGluT1/2 were almost undetectable ( Supplementary Fig. 3 ). Fig. 3 ).
Cortical interneurons are conventionally categorized based on neuropeptide and Ca 2+ binding protein expression 16 . Of those markers, we found that somatostatin (SST) was most highly expressed; calbindin (CB or CALB1), calretinin (CR or CALB2), and neuropeptide Y (NPY) were also robustly detected; little parvalbumin (PV) or vasoactive intestinal polypeptide (VIP) was detected ( Supplementary Fig. 3 ). Thus, mRNA profiling suggests that AMD-iN cells resemble forebrain GABAergic neurons derived from the ganglionic eminences.
Ascl1 and dlx2 are sufficient to generate GABAergic cells
We previously observed that Ascl1 alone can generate glutamatergic iN cells from fibroblasts and ES cells, and it induces endogenous MYT1L expression 14 . We thus speculated that AD may be sufficient to induce GABAergic iN cells. While AD-induced cells displayed less complex morphology during the early stage, the morphology improved over time and was comparable to that of AMD-iN cells by day 6 after transgene expression (Fig. 2a) . Indeed, qPCR analysis demonstrated that endogenous MYT1L and its family members MYT1 and ST18 were induced around day 4 (Fig. 2b) . MYT1L protein persisted in AD-iN cells for at least 5 weeks (Fig. 2c) . Next, we asked whether the absence of Myt1l as an exogenous factor would impact neuronal specification. At 5 WPI, we observed that almost all neurons expressed the forebrain marker FOXG1 (93.5% ± 2.7%) and GABAergic neuron markers such as GABA (89.1% ± 3.5%), DLXs (88.5% ± 1.4%) and GAD65/67 (94.4% ± 4.2%) based on immunofluorescence analysis (Fig. 2d-f) . For a more comprehensive characterization, we used qPCR analysis to interrogate the expression of a series of markers in AMD-, AD-and Ngn2-iN cells cocultured with mouse glia. Virtually none of the iN cells expressed progenitor cell markers (NES, SOX1, OLIG2) (Fig.  2g(i) ). The glutamatergic neuron marker vGluT1 was only detected in Ngn2-iN cells, whereas GABAergic markers (vGAT, GAD1/2, DLX1/5/6, GAT1/3) were exclusively found in AMD-and AD-iN cells. We also detected expression of PV, CB, CR, SST, VIP, NYP, NOS1, HTR3A, CCK and Reelin (RELN); however, only CB, CR and SST were consistently expressed in all biological replicates of AMDiN cells (Fig. 2g(ii) ). The expression pattern of these interneuron markers was very similar in AD-iN cells, except that RELN and VIP were also consistently detected. Finally, we compared the expression pattern of transcription factors important for GABAergic neuron specification and found that LHX6, ZEB2 and SATB1 (but not NKX2-1) expression was consistently detected in AMD-and AD-iN cells (Fig. 2g(iii) ). Since LHX6 and SATB1 were detectable in primary cultures of mouse glia, we verified their expression in FACSpurified AD-iN cells. These results show that AMD-and AD-iN cells have a similar morphology and gene expression pattern.
single-cell characterization of Ad-in cells
Given the expression of several mutually exclusive subtype markers in the bulk analysis, we investigated the expression of these genes at the single-cell level. Immunofluorescence analysis showed that ~37% of the neurons were CR-positive, 28% were CB-positive Collybistin hairpin no.
Collybistin hairpin no.
Collybistin hairpin no. and 9% were SST-positive at 5 WPI (Fig. 2h,i and Supplementary  Fig. 4 ). Less than 2% of the AD-iN cells were CR/SST double positive or CB/SST double positive (Fig. 2h,i) . We observed expression of ISL1 in about 20% of the cells and of NR2F2 and PV in a small fraction of AD-iN cells ( Fig. 2j and Supplementary Fig. 4 ).
On the other hand, we detected exceedingly few or no CTIP2-, NKX2-1-, SP8-and DARRP-32-expressing cells.
To expand the panel of markers, we performed single-cell qPCR on AD-iN cells at 5 WPI. Confirming our immunostaining results, ~80% of the cells that expressed any Ca 2+ -binding proteins or SST (41 cells) expressed either CB (22 cells), CR (4 cells), or SST (7 cells) (Fig. 2k) . We also found several cells expressing CCK, a gene frequently expressed among human cortical interneurons 17 . The low frequency of PV-positive neurons was potentially due to the late developmental expression of this marker 1, 2, 4, 18 . Previous studies showed that accelerated generation of motor neurons from PSCs could be achieved by the use of Notch inhibitors 19 . Indeed, when we treated AD-iN cells with a γ-secretase inhibitor (DAPT), we observed improved complexity of the neuronal morphology in terms of neurite arborization (Supplementary Fig. 5 ). However, DAPT treatment did not enhance the appearance of PV-expressing cells.
Prolonged culture increases synaptic maturation
To characterize the functional properties of AD-iN cells, we performed patch-clamp recordings from cells at 5 and 7 WPI. We found that AD-iN cells, at both timepoints, elicited spontaneous and current-induced action potentials and expressed voltage-gated ion channels (Fig. 3a,b and Supplementary Fig. 6 ). Their intrinsic membrane properties, including capacitance and input resistance, were similar between the two timepoints; but upon coculturing with glutamatergic Ngn2-iN cells, AD-iN cells showed improved maturation in terms of larger cell sizes and more ion channels in their membranes (Fig. 3a,b) . Resting membrane potential was not affected by coculture. We then analyzed the synaptic properties of AD-iN cells. Immunoblotting showed that a large panel of synaptic markers was robustly expressed at 5 WPI (Supplementary Fig. 6 ). Moreover, MAP2-positive dendrites were decorated with the presynaptic proteins SYN1 and vGAT in a punctate pattern, which suggested the formation of GABAergic synapses (Supplementary Fig. 6 ). Spontaneous and evoked IPSCs could be readily recorded at 5 and 7 WPI, but both frequency and amplitude of synaptic events were increased at least two-fold by 7 WPI, showing a progressive maturation of inhibitory synapses in AD-iN cells even after 5 WPI (Fig. 3c,d , and Supplementary Fig. 6 ). As expected, AD-iN cells cocultured with Ngn2-iN cells were also able to receive excitatory synaptic inputs from neighboring neurons (Fig. 3e) .
transgene-independent stability of GABAergic phenotype
To assess whether the cellular identity of AD-iN cells requires continuous transgene expression, we withdrew doxycycline at various timepoints after infection and characterized the iN cells at 4 WPI. 14 d of doxycycline treatment was sufficient to generate stable neuronal cells in vitro (Supplementary Fig. 7) . In order to evaluate the cell-fate stability of iN cells more rigorously, we collected EGFP-labeled AD-iN cells at day 14 and injected them into the subventricular zone and cerebral cortex of newborn severe combined immunodeficient (SCID) mice.
Ample human cells had engrafted 2 weeks post-transplantation as revealed by staining for human-specific nuclear antigen (HuNu) and EGFP (Supplementary Fig. 8 ). The majority of the cells remained close to the injection core and expressed the neuronal marker Doublecortin (DCX). By 3 months post-transplantation, most cells expressed the neuronal marker NeuN and GABA (Supplementary Fig. 8) . We also noticed that NeuN expression increased over time, which suggested the continuous maturation of AD-iN cells in vivo. Similar to their differentiation in vitro, we observed SST, CR and CB expression in the grafted cells. We also detected suggestive colabeling of human cells with NPY and PV antibodies (Fig. 3f) . Thus, GABAergic AD-iN cells are transgene independent and can stably integrate into the rodent brain, where they continue to mature.
Collybistin in human GABAergic synaptic transmission
Finally, we explored whether the GABAergic iN cells can be used to study inhibitory synapse function and uncover cellular phenotypes of a disease condition. Collybistin is a core component of inhibitory postsynapses and regulates the submembrane clustering of GABA A Rs 20, 21 . Loss-of-function mutations in collybistin have been associated with X-linked mental disorder, epilepsy and hyperekplexia 22, 23 . We performed shRNA-mediated knockdown (KD) of collybistin in iN cells using five shRNA constructs, and this KD resulted in significant reduction in collybistin expression with variable efficiencies (Fig. 4a and Supplementary Fig. 9 ). Strikingly, collybistin KD constructs caused a reduction of peak amplitude and total charge transfer of IPSCs upon local GABA administration ( Fig. 4b-d ), which suggested that expression level of collybistin directly affects the number of surface GABA receptors in human neurons. Next, we quantified inhibitory synaptic properties and found a reduction of both amplitude and frequency of spontaneous IPSCs in iN cells following collybistin KD (Fig. 4e-g ). This effect was specific for inhibitory synapses, as there was no change in spontaneous EPSCs or intrinsic membrane properties (Supplementary Fig. 9 ). These findings are similar to findings in mouse collybistin mutant neurons 24 . Thus, the GABAergic iN cells are a valuable tool for studying inhibitory synaptic transmission in human neurons.
discussion
In this study, we showed that the combination of the two transcription factors Ascl1 and Dlx2 is sufficient to convert human PSCs into essentially pure cultures of GABAergic neurons. The cells are generated in a single conversion step and reach synaptic maturity after 5 weeks. Given the importance of inhibitory neurotransmission in health and disease, AD-iN cells will likely become a critical addition in the portfolio of cell types to model diseases with human cells.
Several groups have reported stepwise maturation of GABAergic interneurons through a PSC-derived MGE-like intermediate 1, 2, 4 . Remarkably, transient expression of AD is sufficient to generate a panel of GABAergic neurons that are surprisingly similar to those matured from MGE-like cells, but AD expression requires much less time. Some functional properties of 7-week AD-iN cells (e.g., input resistance and resting membrane potential) were strikingly similar to those of MGE-like cells 10 weeks after differentiation (i.e.,15 weeks after PSC differentiation). Meanwhile, the peak voltage-gated Na + and K + channel currents and membrane capacitance of AD-iN cells were more comparable to those of progenitor-derived interneurons at 25 weeks after differentiation 2 . Apparently, the transcription factors induce not only specification but also an accelerated maturation program. It is worth noting that when human MGE-like cells were cocultured with mouse embryonic cortical neurons, prominent inhibitory synaptogenesis could be detected after ~4 weeks 1 , suggesting the feasibility of enhanced maturation of human MGE-like cell in vitro.
The fact that AD proved most competent to induce GABAergic neurons is well supported by a large body of literature [25] [26] [27] [28] [29] . For instance, both Ascl1 and Dlx2 are prominently expressed in germinal zones that produce GABAergic neurons, and ectopic expression of either factor in cortical progenitors induces markers of GABAergic neurons 25, 29 . Ascl1 mutant mice show an aberrant development of ganglionic eminences [25] [26] [27] [28] . Dlx2, in conjunction with other Dlx factors, is important for GABAergic neuron generation and migration 15, [27] [28] [29] [30] . The many AD expression domains during development may explain why AD induces multiple GABAergic subtypes from PSCs. However, not all neuronal subtypes generated from AD progenitors are produced from PSCs by AD expression, which suggests that additional factors may be required to generate these specific lineages.
In the future, it will be important to explore whether transcription factor combinations can generate selective interneuron subtypes such as PV interneurons. Surprisingly, combining Ascl1 and Dlx2 with additional subtype-specific transcription factors did not result in different subclasses of GABAergic neurons (Supplementary Fig. 10) . Consistently, simultaneous expression of Asc1, Dlx2, Lhx6 and miR-9/9*-124 was recently shown to induce a GABAergic cell population similar to that induced by only Ascl1 and Dlx2 31 . This suggests that timing and cellular context are critical for productive engagement of some transcription factors to specify specific neuronal subtypes 3 . While there is a wealth of information about mouse GABAergic neurons such as molecular markers, morphology and electrophysiological properties, similar depth of information for primary human GABAergic neurons is only emerging. Better characterization of primary human neurons will greatly facilitate the interpretation of properties of neurons generated in vitro, such as the GABAergic AD-iN cells described in this paper. methods Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. manufacturer's protocol. Subsequently, libraries were prepared following the dUTP protocol 37 . Sequencing reads (100 bp) were generated on Hi-Seq 2000 Illumina platforms. Given that the samples contained a mixed population of human and mouse cells, paired-end reads were aligned to both the human reference sequence NCBI Build hg19 and the mouse reference sequence NCBI Build 37/mm9 with TopHat (v1.1.3) 38 . Properly paired reads were extracted using the samtools function. Only properly paired reads to the human reference were considered for subsequent analysis. Expression levels of RefSeq-annotated genes were calculated in units of reads per kilobase of exon model per million mapped fragments (RPKM). Genes with low RPKM (average log 2 RPKM across all samples less than 1) were removed. Differential expression analysis was performed using Students' t-test function "t.test" in R, and genes with P value < 0.05 and at least two-fold expression change were defined as significant.
Gene expression analyses.
For quantitative RT-PCR analyses of pooled cultured cells, RNA was isolated using the RNAqueous Kit (Applied Biosystems), treated with DNase (Applied Biosystems) and reverse transcribed with Superscript III (Invitrogen). mRNA levels were quantified by RT-PCR assay using the Applied Biosystems 7900HT Fast real-time PCR system and RQ analysis software. For quantitative RT-PCR analyses of single cells, single EGFP-labeled iN cells (n = 1) were sorted by FACS into individual wells of 96-well PCR plates using a protocol built into the FACSAriaII flow cytometer's software package, and mRNA levels were measured using the Fluidigm Biomark dynamic array system as previously described 39 . Information on TaqMan assays used in the expression assay can be found in Supplementary Table 2 . Human specific primer sets used to analyze collybistin mRNA expression included collybistin forward (5′-ATGATTGACA TTGCTATCGA-3′) and reverse (5′-CCAGTCTAGG ACAGAAGCC-3′); GAPDH forward (5′-TTGAGGTCAA TGAAGGGGTC-3′) and reverse (5′-GAAGGTGAAG GTCGGAGTCA-3′).
Electrophysiology. For electrophysiological characterization, iN cells were cocultured with mouse glia for an additional 4 to 6 weeks. Electrophysiology experiments were performed similarly to those described 40 . In brief, voltage-clamp recordings were performed in whole-cell configuration with internal solution containing (in mM): 135 CsCl 2 , 10 Hepes, 1 EGTA, 1 Na-GTP, and 1 QX-314 (pH adjusted to 7.4, 310 mOsm); whereas current-clamp internal solution contained (in mM): 130 KMeSO 3 , 10 NaCl, 10 HEPES, 2 MgCl 2 , 0.5 EGTA, 0.16 CaCl 2 , 4 Na 2 ATP, 0.4 NaGTP, and 14 Tris-creatine phosphate (pH adjusted with KOH to 7.3, 310 mOsm). The bath solution contained (in mM): 140 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES-NaOH (pH 7.4).
Membrane potentials were maintained around −60 mV, and a series of step currents with incremental amplitude (10-12 steps, with 10 pA increment) were injected to elicit action potentials, except for spontaneous action potential recordings where resting membrane potential was not adjusted. Na+/K+ currents were recorded in voltage-clamp mode at a holding potential of −70 mV with step-voltage changes as indicated. Evoked synaptic currents were elicited essentially as previously described 41 using an extracellular concentric bipolar stimulating electrode (FHC) connected to an Isolated Pulse Stimulator 2100 (A-M Systems). Pharmacological reagents used were Picrotoxin (50 µM, Tocris, GABA A R blocker) and CNQX (50 µM, Tocris, AMPAR blocker). All recordings were performed at room temperature.
Data presentation and statistics. All data shown are mean ± s.e.m.; all statistical analyses were performed using Student's t-test (except when mentioned otherwise), comparing the test sample with the control sample examined in the same experiments.
Data availability statement. All sequencing data that support the findings of this study have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO) and are accessible through the GEO Series accession number GSE97710. All other relevant data are available from the corresponding author on request.
